Latest Commercialisation News

EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.

FBR Limited wraps up its US Demonstration Program, secures $6.3 million in capital, and appoints Mark Pivac as CEO amid a 70% cost reduction drive. Strategic collaborations with Samsung Heavy Industries and Liebherr signal broader automation ambitions.

Dotz Nano has successfully demonstrated its DotzEarth direct air capture technology at lab scale and secured a A$4 million investment to advance to real-world pilot testing, signaling growing momentum in its carbon capture ambitions.

Clarity Pharmaceuticals reports a robust cash position and strategic refocus on its lead prostate cancer asset, Cu-SAR-bisPSMA, supported by multiple FDA Fast Track designations and advancing clinical trials.

Nanollose Limited has achieved a significant milestone by blending its Nullarbor-20™ sustainable fibre with Australian merino wool to produce pilot blankets, while also completing a $672,000 placement to fund ongoing commercialisation efforts.

Audio Pixels Holdings Limited reports significant progress in its MEMS fabrication and ASIC development, targeting wafer completion by Q2 2025 while managing funding and ASX suspension challenges.

State Gas Limited advances its Rolleston West Project with successful drilling of two vertical wells confirming coal and gas continuity, aiming to establish a maiden 2P reserve. Concurrently, the company expands its high density natural gas supply, targeting significant revenue growth through a six-truck dual fuel trial.

Metgasco Limited reported a modest quarterly profit supported by steady gas production from its Odin and Vali fields, while approving a production uplift program to boost future output. Despite challenges including flooding delays and lower LPG sales, the company secured a six-year licence renewal, positioning it for growth in the Cooper Basin.

Redcastle Resources advances its Eastern Goldfields exploration with significant high-grade gold intercepts across three key prospects, setting the stage for upcoming resource estimates and development studies.

TMK Energy has successfully doubled the capacity of its Gurvantes XXXV pilot well project with three new wells, achieving record monthly gas production and securing $2.3 million in fresh capital to advance commercialisation.

1414 Degrees Ltd advances its transformation into a full-service decarbonised energy provider, delivering key technology and commercial milestones in Q3 FY25 while maintaining a stable cash position.

Vectus Biosystems advances its lead fibrosis drug VB0004 with validated Phase I safety data and strategic cost reductions, while actively pursuing licensing partnerships in China.